177Lu-PP-F11N

Lutetium-177-PP-F11N · University Hospital Basel

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 177Lu-PP-F11N, covering 2025-02-24 to 2025-02-24. Get the full timeline:

Most recent: Clinical Trial Update: 177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer. [Phase 1]